Patent · US Active

Compounds

US8338587B2 · kind B2 · utility

0Cited by

7References

7Claims

0Family size

Assignee

ASTRAZENECA AB · SE

Inventors

Frank Burkamp · Chelmsford, GB
Peter Hansen · Staffanstorp, SE
Balint Gabos · Lund, SE
Håkan Bladh · Lund, SE

Key dates

Filing date	Mar 30, 2010
Grant date	Dec 25, 2012
Priority date	—
Expiry date	Aug 16, 2030

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07J71/0047
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention provides named compounds of formula (I)and pharmaceutical compositions containing them and their use in therapy.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.